Company intelligence / Profile preview
Tianjin Institute of Pharmaceutical Research
Tianjin, Tianjin, Chinaen.tipr.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TIPR has over six decades of experience in pharmaceutical innovation with more than 200 new drug certificates. It has developed several first-in-China products such as Suxiao Jiuxin Pill and Maren Soft Capsules. Its pipeline covers cardiovascular/cerebrovascular disease treatments, mental health medications like pipotiazine palmitate for schizophrenia (approved), anti-arrhythmic agents like aprindine hydrochloride (approved), digestive disorder therapies in late-stage trials, among others. The institute maintains GMP-certified manufacturing facilities and robust global registration/commercialization capabilities.
- Therapeutic areas
- OncologyEndocrinologyImmunologyPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule drugsHerbal medicinesFusion proteinsAPIs (Active Pharmaceutical Ingredients)Oral solid preparationsInjections and soft capsules
- Industry
- Pharma
02
Drug pipeline
19 assets18 more assets in the full pipeline.
03
Partnerships
No specific major international partnerships disclosed; collaborates within China Merchants Group ecosystem.
Beyond the preview
Go deeper on Tianjin Institute of Pharmaceutical Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjin Institute of Pharmaceutical Research.